Aspergillus nidulans Infection in Chronic Granulomatous Disease
about
Aspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interactionRoles of Rack1 Proteins in Fungal PathogenesisTreatment of invasive aspergillosis with posaconazole in patients who are refractory to or intolerant of conventional therapy: an externally controlled trialPhellinus tropicalis abscesses in a patient with chronic granulomatous disease.Quantitative trait locus (QTL) mapping reveals a role for unstudied genes in Aspergillus virulence.Role of NADPH oxidase versus neutrophil proteases in antimicrobial host defense.Treatment options in Invasive Aspergillosis.Rasamsonia argillacea species complex: taxonomy, pathogenesis and clinical relevance.Penicillium piceum infection: diagnosis and successful treatment in chronic granulomatous disease.Geosmithia argillacea: an emerging cause of invasive mycosis in human chronic granulomatous disease.Current treatment options for chronic granulomatous disease.Capsular polysaccharides from Cryptococcus neoformans modulate production of neutrophil extracellular traps (NETs) by human neutrophilsWhen the Fight against Fungi Goes WrongGenetic Susceptibility to Fungal Infections in Humans.Molecular identification of bacterial DNA in the chorioretinal scars of chronic granulomatous disease.Modern management of chronic granulomatous disease.Genetic Susceptibility to Fungal Infections: What is in the Genes?Invasive fungal infections in pediatric patients: a review focusing on antifungal therapy.Osteomyelitis due to Aspergillus species in chronic granulomatous disease: an update of the literature.Invasive mold infections in chronic granulomatous disease: a 25-year retrospective survey.Invasive aspergillosis: resistance to antifungal drugs.Treatment of candidiasis: insights from host genetics.Pulmonary manifestations of chronic granulomatous disease.The use of biomarkers and molecular methods for the earlier diagnosis of invasive aspergillosis in immunocompromised patients.Epidemiology and molecular mechanisms of antifungal resistance in Candida and Aspergillus.Antifungal Resistance: An Emerging Reality and A Global Challenge.Fulminant mulch pneumonitis: an emergency presentation of chronic granulomatous disease.The First Case of Invasive Mixed-Mold Infections Due to Emericella nidulans var. echinulata and Rasamsonia piperina in a Patient with Chronic Granulomatous Disease.Adrenal and hepatic aspergillosis in an immunocompetent patient.Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children.Posaconazole as salvage therapy in patients with chronic granulomatous disease and invasive filamentous fungal infection.Intrinsic in vitro susceptibility of primary clinical isolates of Aspergillus fumigatus, Aspergillus terreus, Aspergillus nidulans, Candida albicans and Candida lusitaniae against amphotericin B.Aspergillosis in Chronic Granulomatous Disease.Phenotypic Prenatal Diagnosis of Chronic Granulomatous Disease: A Useful Tool in The Absence Of Molecular Diagnosis.The Absence of NOD1 Enhances Killing of Aspergillus fumigatus Through Modulation of Dectin-1 Expression.Culture-positive invasive aspergillosis in a medical center in Taiwan, 2000-2009.Antifungal activity of human polymorphonuclear and mononuclear phagocytes against non-fumigatus Aspergillus species.Chronic granulomatous disease of childhood: an unusual cause of recurrent uncommon infections in a 61-year-old man.
P2860
Q26864717-756F375F-ED99-4FC9-9F9F-A0113D3C4CFEQ28069763-48430F73-7EFA-4D4F-83A6-3CBA62DD2982Q28277029-55559EA6-5A84-44EF-A302-333F45903751Q33840702-B90CB978-9BEA-47F1-8408-4BFC07EDFFC1Q33895013-9828AB80-EACC-47D1-B537-5719975708B9Q34098141-89006C65-7DA7-470A-80E4-F3300DE7CFC4Q34357504-1609568A-5961-4A66-8572-05DB936A7D5CQ34360893-98CA4172-806B-4F56-9C6D-C0F81CB0555BQ34584769-D5A82144-251F-422D-9270-15F4F445CBAAQ34626970-9908AD48-F8C9-4DB3-B848-E9C9F8ECCE1EQ34706880-D83747FB-8BD2-4FE6-9F54-9A24C1A91DC0Q35011899-52BADC27-322C-4F0F-AE4C-8A4BD6EB98DFQ35914364-CB1DB69F-1195-4EE4-A17F-B93B8AE8548AQ36330018-06F423DD-D7D3-4B40-81C8-ED723BA32B3AQ36965983-FAF68396-E06F-4590-BFDF-3D712E9FC953Q37064440-98076CA2-BAFF-469E-AD26-D0DA5D53B341Q37183884-2369B680-8FE5-4246-9CFB-E982AD6F2ABFQ37682908-E3BE7B0C-5E34-4932-BC23-7FD92E07BCA5Q37880202-8CAA0FA6-A990-4DDD-B49F-152184670ADBQ37955638-FB66EC13-E5B5-46B8-9251-08A9C229C5B5Q37983464-19987343-6588-4064-895F-28ECED519A54Q38048853-C0C23364-390F-431E-A1D2-04128FA3895EQ38079835-841F91A2-1738-4B76-9224-4EF4C994EF72Q38508539-FEE33B15-11F5-48FB-BB60-379D3FFCB751Q38711698-FD194542-DCD4-4C83-8AB0-73EBB3321130Q40040795-FE17BB45-7FB0-4D29-9586-862E3C22750AQ40441305-46B62C6A-0046-438F-BFCD-5DA9BAD56051Q40911977-BBE7C8F5-171D-4B77-AB76-688460CDC3CBQ41477322-451B652F-4363-480C-8352-3BA264B97F60Q41929675-6673CC5F-161D-4F42-85F2-CF1C6D720A02Q46486677-B5BAEE84-B003-4A9B-A6B3-3989D50A576FQ46934279-5423C498-58BF-431E-84BA-9D0F29562DDAQ47645142-9FFBA7AF-813B-43D6-8452-FA6C21EE0CDAQ47734654-54B55A84-8573-46F5-9DCE-CC9D353C53D1Q49475532-46AE5F29-2881-48A7-865F-510601CBE359Q51174005-0CEA5259-DB9D-46C5-999A-0547CB4E6999Q51190391-2566FA1D-E4A5-4787-A36F-0F18D937A1BCQ54368633-3FEEB5D7-F8FC-459E-8288-A954ACFD0B3F
P2860
Aspergillus nidulans Infection in Chronic Granulomatous Disease
description
article
@en
im September 1998 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована у вересні 1998
@uk
name
Aspergillus nidulans Infection in Chronic Granulomatous Disease
@en
Aspergillus nidulans Infection in Chronic Granulomatous Disease
@nl
type
label
Aspergillus nidulans Infection in Chronic Granulomatous Disease
@en
Aspergillus nidulans Infection in Chronic Granulomatous Disease
@nl
prefLabel
Aspergillus nidulans Infection in Chronic Granulomatous Disease
@en
Aspergillus nidulans Infection in Chronic Granulomatous Disease
@nl
P2093
P1433
P1476
Aspergillus nidulans infection in chronic granulomatous disease
@en
P2093
E S DeCarlo
J I Gallin
K J Kwon-Chung
S M Holland
P304
P356
10.1097/00005792-199809000-00004
P407
P50
P577
1998-09-01T00:00:00Z